Keywords: GlaxoSmithKline, MenHibrix, USA, FDA, Meningococcal, Haemmophilus b tetanus

FDA approves GlaxoSmithKline's new combo vaccine MenHibrix

Article | 18 June 2012

Print This

The US Food and Drug Administration has approved US pharma giant GlaxoSmithKline’s (LSE: GSK) MenHibrix (meningococcal groups C ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in